Molecular Diagnostics


Clonal Hematopoiesis of Indeterminate Potential Associated with hsC-Reactive Protein
Clonal hematopoiesis (CH) occurring in normally aging subjects, initially suggested by X-chromosome inactivation studies, is caused by acquired mutations in genes recurrently mutated in hematological cancers, and in non-driver candidates. More...14 Jul 2020

Combined DNA/RNA Liquid Biopsy Test Identifies Genetic Aberrations in Metastatic Prostate Cancer
Analysis of cell-free DNA and RNA in liquid biopsy samples revealed aberrations in the gene coding for the androgen receptor (AR), which were related to effectiveness of drug treatment and survival time in patients with castration-resistant prostate cancer (mCRPC). More...14 Jul 2020


Early-Onset Preeclampsia Risk Reflected in Circulating Maternal Transcripts
Preeclampsia is a poorly understood pregnancy-associated disorder. Often marked by hypertension, preeclampsia can lead to severe complications including internal bleeding, seizures, stroke, premature birth, and death. More...13 Jul 2020

Rapid Genomic Profiling of Colon Cancers Improves Therapy Selection
Colorectal cancer is a malignant tumor arising from the inner wall of the large intestine (colon) or rectum. Colorectal cancer is the third leading cause of cancer in both men and women in the USA. Most colorectal cancers develop from polyps. Removal of colon polyps can aid in the prevention of colorectal cancer. More...09 Jul 2020
Gut Microbiome Metabolomic Profiles Are Diagnostic for Liver Diseases
Liver disease researchers have developed a noninvasive method to diagnose nonalcoholic fatty liver disease (NAFLD) and predict progression to cirrhosis by analyzing metabolomic profiles produced by the microorganisms living in the gut (the microbiome). More...08 Jul 2020
In Other News
DNA Sequencing Technique Unravels Genetic Diversity of Cancer Tumors
An Eight MicroRNA Biomarker Panel for Diagnosis of ALS
RNA Sequencing as Alternative to Immunohistochemistry in Cancer Diagnostics
Blood Group Locus Contributes to COVID-19 Severity Risk
Precision Medicine-Based Genetic Testing Developed for Prostate Cancer
Sensitive and Accurate Cancer Detection Through Analysis of Circulating Free DNA Methylation Patterns
Highly Sensitive Liquid Biopsy Technique Brings Personalized Cancer Monitoring a Step Closer
Gut Microbiome Dysbiosis Characterized in Parkinson’s Disease
Serum Mir‐22 Prognostic Marker Explored for Acute Myeloid Leukemia
Isothermal Amplification Method Used to Detect Salmonella Subtypes
Serum Neurofilament Light Chain Is a Potential Prognostic Biomarker for Frontotemporal Lobar Degeneration
Diagnosing Liver Cancer by Screening Viral Exposure History
A Novel Liquid Biopsy Device Enables Early Cancer Detection and Diagnosis
Blood Test Predicts Prostate Cancer Treatment Response
A Simple Paper-Based, Wearable Device for Long Term Sweat Analysis
Sensitive Separation Device Enables Diagnostic Analysis of Cancer Exosomes
Tumor Mutation and Immune Microenvironment Revealed in Colorectal Cancer
Polygenic Risk Scores Highlight Potential for Developing Coronary Artery Disease
Streamlined Assay Improves Prenatal Detection of Alpha-Thalassemia
Precision Oncology Confers Clinical Benefit in Relapsed Pediatric Cancer
Blood Protein Biomarkers Predict Outcome of a Patient’s COVID-19 Infection
Study Evaluates Molecular Diagnostics Tests for SARS-CoV-2
Saliva-Based Assay Developed for HPV-Driven Oropharyngeal Cancer
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.







